Welcome to EQUITY DEVELOPMENT
The UK's longest established regulated provider of sponsored equity research.
We launched EQUITY DEVELOPMENT in 1997 becoming the first ever regulated provider of Sponsored Equity Research in the UK.
Our research teams are made up of expert analysts with deep understanding & experience in their sectors. Our research is distributed to all relevant investment classes & commentators. (at no cost to the reader).
We have made our name by specialising in those companies who are not receiving the attention that they merit, using detailed commentary, appropriate valuation metrics and regular publications to help eradicate undervaluation in the medium term.
Search for Company Research
FREE REGISTRATION
Sign up today and access the very latest company research
LOG IN
For access to all company research please
Phynova Group Plc
Phynova Group Plc (PYN) is a UK-based, semi-virtual pharmaceutical development company focused on the discovery and development of plant-derived prescription drugs for the treatment of viral and bacterial infections, metabolic diseases and cancer.
Review of Progress
Structure of both the operations and the organisation strengthened
Drug development program moving forward on track
£1.4m cash at year end, bolstered by subsequent equity placement
Subject to financing, Group’s potential not reflected in current share levels
Publication Date:
April 10 2008
A discovery engine for Botanical drugs
- Plant-derived medicines (Botanical Drugs) now embraced by FDA
- Efficacy and safety concerns reduced through historic use in China
- Current valuation reflects lack of understanding in new approach: shares can double as awareness grows
Publication Date:
June 14 2007